Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Lovell

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature: New Biology|July 7, 1971
Prolactin synthesis in primatesA D Rudko, F M Lovell, B W Low
Expert Opinion on Pharmacotherapy|February 28, 2026
Progress, potential and pitfalls of ketamine as a treatment for Depression and related disordersDiana K Orsini, Sara Di Luch, Gabrielle F M Lovell, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2026
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic reviewShreya Vasudeva, Gabrielle F M Lovell, Sabrina Wong, et al.
Journal of Bacteriology|September 15, 2022
Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal EnvironmentKarine Dufresne, Vladyslav A Podskalniy, Christine A Herfst, et al.
General Hospital Psychiatry|April 21, 2026
Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic reviewGabrielle F M Lovell, Shreya Vasudeva, Diana K Orsini, et al.
Journal of Medicinal Chemistry|May 1, 1981
1-Aryl-3-azabicyclo[3.1.0]hexanes, a new series of nonnarcotic analgesic agentsJ W Epstein, H J Brabander, W J Fanshawe, et al.
JAMA Psychiatry|April 15, 2026
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic ReviewDiana K Orsini, Sabrina Wong, Sara Di Luch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature: New Biology|July 7, 1971
Prolactin synthesis in primatesA D Rudko, F M Lovell, B W Low
Expert Opinion on Pharmacotherapy|February 28, 2026
Progress, potential and pitfalls of ketamine as a treatment for Depression and related disordersDiana K Orsini, Sara Di Luch, Gabrielle F M Lovell, et al.
Journal of Psychopharmacology (Oxford, England)|June 24, 2026
Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic reviewShreya Vasudeva, Gabrielle F M Lovell, Sabrina Wong, et al.
Journal of Bacteriology|September 15, 2022
Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal EnvironmentKarine Dufresne, Vladyslav A Podskalniy, Christine A Herfst, et al.
General Hospital Psychiatry|April 21, 2026
Evaluating the potential risk of ketamine-induced hepatotoxicity in the treatment of mood and anxiety disorders: A systematic reviewGabrielle F M Lovell, Shreya Vasudeva, Diana K Orsini, et al.
Journal of Medicinal Chemistry|May 1, 1981
1-Aryl-3-azabicyclo[3.1.0]hexanes, a new series of nonnarcotic analgesic agentsJ W Epstein, H J Brabander, W J Fanshawe, et al.
JAMA Psychiatry|April 15, 2026
Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic ReviewDiana K Orsini, Sabrina Wong, Sara Di Luch, et al.
Pageof 1